Apollomics (APLM) Scheduled to Post Earnings on Thursday

Apollomics (NASDAQ:APLM) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, March 28th. Analysts expect Apollomics to post earnings of ($0.15) per share for the quarter.

Apollomics Stock Performance

Apollomics stock opened at $0.55 on Wednesday. Apollomics has a 52 week low of $0.52 and a 52 week high of $49.00. The business has a 50-day simple moving average of $0.72 and a 200 day simple moving average of $1.30.

Hedge Funds Weigh In On Apollomics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in APLM. Citadel Advisors LLC purchased a new position in Apollomics during the fourth quarter worth about $53,000. Geode Capital Management LLC purchased a new position in Apollomics during the first quarter worth about $325,000. Finally, BlackRock Inc. purchased a new position in Apollomics during the second quarter worth about $38,000. 19.13% of the stock is currently owned by hedge funds and other institutional investors.

About Apollomics

Apollomics, Inc, a biopharmaceutical company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.